Connect your AI

Avanos Medical AVNS Thereafter

Other financials

Income statement

Revenue$182.2M+8.8%

Gross profit$94.2M+4.9%

Operating income$8.9M-13.6%

Net income$5.1M-22.7%

EPS (diluted)$0.11-21.4%

Balance sheet

Cash & equivalents$65.6M-32.4%

Total debt$138.4M-1.8%

Total equity$782.1M-6.8%

Total assets$1.1B-5.2%

Cash flow

Operating cash flow-$12.3M-148%

CapEx$4.3M-35.8%

Free cash flow-$16.6M-187%

Valuation

Market cap$1.17B+108%

Enterprise value$1.24B+105%

P/S1.6×+0.8×

Profitability

Gross margin50%-4.6pp

Operating margin-9.1%-4.2pp

Net margin-10.4%-4.7pp

FCF margin1.6%-14.9pp

Returns & leverage

Return on equity-9.2%-3.9pp

Debt / equity0.2×0.0×

Current ratio2.5×-0.1×

Where this comes from

Reported directly by Avanos Medical in its filing.

Tagged under the XBRL concept avns:FiniteLivedIntangibleAssetExpectedAmortizationAfterYearFour.

The official record: Avanos Medical’s 10-Q, filed May 5, 2026, on SEC EDGAR. View the filing →

Ask your AI about Avanos Medical's thereafter.

Connect your AI assistant and see it in context, right in your chat.

Connect your AI

Harbor at dusk

Questions, answered.

What is Avanos Medical's thereafter?: Avanos Medical (AVNS) reported thereafter of $39.2M in Q1 2026.
How has Avanos Medical's thereafter changed year-over-year?: Avanos Medical's thereafter increased by 7.1% year-over-year, from $36.6M to $39.2M.